New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Access the report

›ETF Issuers›Simplify›PINK

PINK

Simplify Health Care ETF

Active ETF Equity Theme: Healthcare Technology & Innovation

Not rated

The PINK Exchange Traded Fund (ETF) is provided by Simplify. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

$40.19

+$0.11 (+0.27%) yesterday

2:30 PM 11/03/26 Closed

1D price range

$40.10$40.60

52W price range

$32.03$41.20

YTD Perf.

+10.08%

YTD Flows

Annualized volatility

Fund AuM

€303M

Share class AuM

€303M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

US82889N7729

TER

0.51%

Inception date

10/7/2021

Issuer

Simplify

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
PBE Invesco Dynamic Biotechnology & Genome ETF	+1.63%
TMED T. Rowe Price Health Care ETF	-0.19%
IHE iShares U.S. Pharmaceuticals ETF	+3.13%
PJP Invesco Dynamic Pharmaceuticals ETF	+2.00%
IBBQ Invesco Nasdaq Biotechnology ETF	+1.61%
203780 Mirae Asset TIGER NASDAQ BIO ETF	+4.03%
BTEE iShares Nasdaq US Biotechnology UCITS ETF	+1.60%
00678 CAPITAL NASDAQ BIOTECHNOLOGY INDEX ETF	+1.48%
WDNA WisdomTree BioRevolution UCITS ETF	+1.34%
WDNA WisdomTree BioRevolution Fund	-0.22%
IBB iShares Biotechnology ETF	+1.59%
IHI iShares U.S. Medical Devices ETF	+3.45%
FTXH First Trust Nasdaq Pharmaceuticals ETF	+2.50%
ZUH BMO Equal Weight U.S. Health Care Index ETF	+2.04%
HTEC Robo Global Healthcare Technology and Innovation ETF	+1.07%

API

PerformanceDec 31, 2025 - Nov 2, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 09/30/26

Healthcare

86.65%

Consumer Cyclicals

5.42%

Non-Energy Materials

4.63%

Consumer Non-Cyclicals

1.69%

Unavailable

1.49%

Other

0.11%

Latest PINK news

No content available for this fund

FAQ about PINK

PINK is an actively managed ETF that invests in the Healthcare Technology segment.

PINK carries a total expense ratio (TER) of 0.51%.

PINK was introduced to the market on October 7, 2021.

Simplify Health Care ETF, PINK, is provided by Simplify. Learn more about Simplify here.

PINK oversees €303M in assets as of November 2, 2026.

PINK follows a distributing dividend policy, meaning it pays out income to investors. As of November 2, 2026, its 12-month trailing yield was 0.75%.

As of September 30, 2026, PINK has significant geographic allocations in USA and Ireland.

As of September 30, 2026, PINK focuses largely on Healthcare, Consumer Cyclicals and Non-Energy Materials.

As of September 30, 2026, PINK holds 52 positions in its portfolio, with 73.46% of assets concentrated in its top 15 holdings.

As of September 30, 2026, PINK top three holdings include Eli Lilly & Co., Humana, Inc. and Arcutis Biotherapeutics, Inc..

The base currency of PINK is USD.

Top 10 holdings

Data as of 09/30/26

Eli Lilly & Co.

10.19%

Humana, Inc.

7.10%

Arcutis Biotherapeutics, Inc.

6.51%

Warby Parker, Inc.

5.42%

Thermo Fisher Scientific, Inc.

5.20%

Johnson & Johnson

5.14%

AbbVie, Inc.

4.88%

Purecycle Technologies, Inc.

4.63%

UnitedHealth Group, Inc.

4.40%

Avantor, Inc.

4.26%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

Trackinsight Global ETF Survey 2026: ETFs' Next Act: From Access to Selection. Access the report

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

Simplify Health Care ETF

FAQ about PINK

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US